ConductScience.org, home

Paper39153293

Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report.

Casey RM and 10 others. Vaccine, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report. Papers, record 39153293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39153293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report.
PubMed
Journal
Vaccine
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.77, provisional
iCite
Revised in PubMed
2025-09-02
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Casey RMRebecca M
2Najjengo MSMarjorie Sserunga
3Lubega IIrene
4Sekiziyivu ABArthur B
5Twinomuhwezi-Oyet EEllon
6Nakato WNWinfred Nansozi
7Sciarratta CNCourtney N
8Chu SYSusan Y
9Doshi RHReena H
10Kambugu AAndrew
11Gidudu JFJane F

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Yellow Fever VaccineMajor topic
Yellow FeverMajor topic
Humans
Infant
Uganda
Male
Female
Single-Blind Method
Vaccination
Drug-Related Side Effects and Adverse Reactions
Immunization Schedule

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CC999999Intramural CDC HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131859201Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis.Vaccine2020https://conductscience.org/library/papers/31859201PubMed
230475808Variation in the quality and out-of-pocket cost of treatment for childhood malaria, diarrhoea, and pneumonia: Community and facility based care in rural Uganda.PLoS One2018https://conductscience.org/library/papers/30475808PubMed
333656136Adverse events following yellow fever vaccination in immunocompromised persons.Rev Inst Med Trop Sao Paulo2021https://conductscience.org/library/papers/33656136PubMed
426086636Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.MMWR Morb Mortal Wkly Rep2015https://conductscience.org/library/papers/26086636PubMed
527784992Yellow fever vaccine-associated viscerotropic disease: current perspectives.Drug Des Devel Ther2016https://conductscience.org/library/papers/27784992PubMed
627378369Adverse event reports following yellow fever vaccination, 2007-13.J Travel Med2016https://conductscience.org/library/papers/27378369PubMed
721640779Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.Vaccine2011https://conductscience.org/library/papers/21640779PubMed
8893464Stabilized 17D strain yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function.J Biol Stand1977https://conductscience.org/library/papers/893464PubMed
918809449Adverse event reports following yellow fever vaccination.Vaccine2008https://conductscience.org/library/papers/18809449PubMed
1015837230Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.Vaccine2005https://conductscience.org/library/papers/15837230PubMed
1120671663Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep2010https://conductscience.org/library/papers/20671663PubMed
1233422245Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.Lancet2021https://conductscience.org/library/papers/33422245PubMed
1324456625Yellow fever vaccine-associated adverse events following extensive immunization in Argentina.Vaccine2014https://conductscience.org/library/papers/24456625PubMed
1426090855Serious adverse events associated with yellow fever vaccine.Hum Vaccin Immunother2015https://conductscience.org/library/papers/26090855PubMed
1530937437Fractional-dose yellow fever vaccination: an expert review.J Travel Med2019https://conductscience.org/library/papers/30937437PubMed
163372545Studies on yellow fever vaccine. III--Dose response in volunteers.J Biol Stand1988https://conductscience.org/library/papers/3372545PubMed
1712941972Prevalence of childhood illnesses and care-seeking practices in rural Uganda.ScientificWorldJournal2003https://conductscience.org/library/papers/12941972PubMed
1816632108Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3).Vaccine2006https://conductscience.org/library/papers/16632108PubMed
1923395587Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.Vaccine2013https://conductscience.org/library/papers/23395587PubMed
2028358792Notes from the Field: Adverse Events Following a Mass Yellow Fever Immunization Campaign - Kongo Central Province, Democratic Republic of the Congo, September 2016.MMWR Morb Mortal Wkly Rep2017https://conductscience.org/library/papers/28358792PubMed

See all 30 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42627790Determinants of post-campaign measles vaccination coverage in Madagascar: A geographically stratified analysis.PLOS Glob Public Health2026https://conductscience.org/library/papers/42627790PubMed
42136579Factors associated with serious adverse event following immunization: a real-world analysis of the vaccine adverse event reporting system 2025.Front Public Health2026https://conductscience.org/library/papers/42136579PubMed
41512502
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final report.
Vaccine2026https://conductscience.org/library/papers/41512502PubMed
40907498Strengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring.Am J Trop Med Hyg2025https://conductscience.org/library/papers/40907498PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39153293

GET https://conductscience.org/api/papers/v1/39153293/references?page=2